“As pioneers focused on shaping the trajectory of the microbiome industry, we are encouraged to continue with our mission of gathering evidence that demonstrates the power of the microbiome and actions to apply it to everyday health.”
SAN FRANCISCO (PRWEB) March 13, 2018
uBiome, the leader in microbial genomics, has been named one of the most innovative companies of 2018 in the data science sector. This prestigious award was given by Fast Company, the world’s leading progressive business media brand focused on innovation in technology, leadership, world changing ideas, and design. This award is the second time Fast Company has recognized uBiome as one of the most innovative companies, having included them in their 2016 Top 10 list of most innovative companies in healthcare.
More than three dozen Fast Company editors, reporters, and contributors surveyed thousands of companies to identify the most notable innovations of the year and evaluate their impact on businesses, industries, and the larger culture.
uBiome’s large dataset and innovations in machine learning, statistical genetics, and other computational methods have enabled greater insights into the developing field of microbiome sequencing and analysis. For more information uBiome’s scientific team and advisory board, peer-reviewed publications and presentations, and IP portfolio, the company’s science page is located here.
“Since 2012, uBiome has worked to improve lives by developing groundbreaking innovations that empower healthcare providers, patients, and consumers to better understand the health impact of the microbiome,” said Jessica Richman, uBiome co-founder and CEO. “We are honored to be recognized for the second time by Fast Company. This achievement underscores the tremendous efforts of our entire team and reinforces our leadership in pioneering significant advances in microbiome research and commercialization.”
“As pioneers focused on shaping the trajectory of the microbiome industry, we are encouraged to continue with our mission of gathering evidence that demonstrates the power of the microbiome and actions to apply it to everyday health,” said Zachary Apte, PhD, co-founder and CTO of uBiome.
The company currently has three products in the market. ExplorerTM is a consumer health and wellness test that has been used by hundreds of thousands of consumers and more than 200 prestigious research institutions around the world to learn more about various microbial ecosystems in the human body. SmartGutTM and SmartJaneTM are medical tests ordered by healthcare providers that allow patients to easily test their gut health and for HPV, STIs, and vaginal microbiome dysbiosis, respectively.
To learn more, please visit http://www.uBiome.com.
uBiome is the leading microbial genomics company. Funded by Y Combinator, Andreessen Horowitz, 8VC, and other leading investors, uBiome pioneered the field of microbial genomics starting in 2012. uBiome’s mission is to transform the science of the microbiome into useful products and services that improve people’s lives.